Position in EXEL
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$22,903
-$87,811 QoQ
Shares Held
534
-78.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
4 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Aster Capital Management (DIFC) Ltd holds $2,069,231 across 43 Biotechnology names. EXEL ranks #8 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IBRX |
ImmunityBio, Inc.
|
182,089 | $1,396,622 | |
| 2 | ANAB |
Anaptysbio, Inc
|
5,218 | $192,926 | |
| 3 | PRAX |
Praxis Precision Medicines, Inc.
|
260 | $83,769 | |
| 4 | BEAM |
Beam Therapeutics Inc.
|
2,954 | $70,393 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
734 | $41,463 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
550 | $41,299 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
140 | $26,467 | |
| 8 | EXEL |
Exelixis, Inc.
This page
|
534 | $22,903 |
All Filings in EXEL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $22,903 | 534 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $110,714 | 2,526 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $10,799 | 245 | Shares | Sole | 2025-08-14 | |
| 2024-09-30 | $387,641 | 14,938 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||